Advertisement
Advertisement
NGEN
N
NervGen Pharma Corp. Common stock
3.66
USDSponsored
-0.22
-5.50%
Mar 26, 15:54 UTC -4
Closed
Pre-Market
3.69
+0.03
+0.96%
NGEN Earnings Reports
Positive Surprise Ratio
NGEN beat 1 of 1 last estimates.
100%
Next Report
Next Week
Date of Next Report
Apr 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.09
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/-30.77%
NervGen Pharma Corp. Common stock earnings per share and revenue
On --, NGEN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bobs Discount Furniture, Inc.
Report Date
Mar 17, 2026 For Q4 25
Estimate
$0.25
Actual
$0.35
Surprise
+35.71%
Public Policy Holding Company, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.65
Actual
$0.79
Surprise
+20.34%
Brazil Potash Corp.
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.07
Surprise
-15.51%
WW International, Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$1.24
Actual
-$0.44
Surprise
+64.55%
Blaize Holdings, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.14
Surprise
+31.37%
Health In Tech, Inc. Class A Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.01
Actual
-$0.01
Surprise
+0.99%
York Space Systems Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.23
Actual
-$0.28
Surprise
-25.81%
XOMA Royalty Corporation Depositary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.15
Actual
$0.26
Surprise
+264.45%
FAQ
What were NervGen Pharma Corp. Common stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, NervGen Pharma Corp. Common stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to NervGen Pharma Corp. Common stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is NervGen Pharma Corp. Common stock expected to report next?
The next earning report is scheduled for Apr 02, 2026.
What are the forecasts for NervGen Pharma Corp. Common stock's next earnings report?
Based on --
analysts, NervGen Pharma Corp. Common stock is expected to report EPS of -$0.09 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement